dc.contributor.author |
Moya-Salazar, Jeel |
|
dc.contributor.author |
Ubidia-Incio, Roberto |
|
dc.contributor.author |
Incio-Grande, Maritza |
|
dc.contributor.author |
Blejer, Jorgelina L. |
|
dc.contributor.author |
Gonzalez, Carlos A. |
|
dc.date.accessioned |
2019-01-25T16:03:20Z |
|
dc.date.available |
2019-01-25T16:03:20Z |
|
dc.date.issued |
2017 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/4755 |
|
dc.description.abstract |
INTRODUCTION: Safety in Transfusion Medicine is subject to regulations and government legislation within a total quality framework. The aim of this study was to evaluate the impact of seroprevalence and indeterminate results on lost units and cost per donation. METHODS: A prospective cross-sectional study was performed in the Blood Bank and Transfusion Therapy Department of the Hospital Central de la Policia Nacional del Peru in Lima, Peru. All completed donations (replacement/voluntary) without complications were included in this study. Every donation met the institutional requirements and quality criteria of Programa Nacional de Hemoterapia y Bancos de Sangre (PRONAHEBAS). Data analysis was achieved using the Statistical Package for the Social Sciences. RESULTS: A total of 7723 donations were evaluated during 2014 and 2015 with 493 being seropositive (overall prevalence 5.25%) and 502 having indeterminate results (overall prevalence 5.35%). Thus total loss was 995units, 437.8L of blood and 49,750 US dollars. The most common seropositive infectious markers were the core antibody of hepatitis B virus (2.82%) and syphilis (1.02%), and the most common indeterminate results were Chagas disease (1.27%) and the core antibody of hepatitis B virus (1.26%). There was no significant change in the prevalence of seropositivity (p-value=0.243) or indeterminate results (p-value=0.227) over the two-year period of the study. A statistical correlation was found between the cost per lost donation and the most prevalent markers (rho=0.848; p-value=<0.001). CONCLUSION: Seroprevalence was lower than the regional mean, but the prevalence of indeterminate results was elevated causing a great impact on blood supply and economic losses to this institution. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Elsevier |
|
dc.relation.ispartofseries |
Revista Brasileira de Hematologia e Hemoterapia |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Blood donor |
en_US |
dc.subject |
Indeterminate screening |
en_US |
dc.subject |
Infectious marker |
en_US |
dc.subject |
Seroprevalence |
en_US |
dc.title |
Seroprevalence, cost per donation and reduction in blood supply due to positive and indeterminate results for infectious markers in a blood bank in Lima, Peru |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1016/j.bjhh.2016.11.007 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.06 |
|
dc.relation.issn |
1806-0870 |
|